Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Shanghai international consensus on diagnosis and comprehensive treatment of colorectal liver metastases (version 2019).
Ren L, Zhu D, Benson AB 3rd, Nordlinger B, Koehne CH, Delaney CP, Kerr D, Lenz HJ, Fan J, Wang J, Gu J, Li J, Shen L, Tsarkov P, Tejpar S, Zheng S, Zhang S, Gruenberger T, Qin X, Wang X, Zhang Z, Poston GJ, Xu J; SINCE (Shanghai International Consensus Expert Group on Colorectal Liver Metastases) Group. Ren L, et al. Among authors: koehne ch. Eur J Surg Oncol. 2020 Jun;46(6):955-966. doi: 10.1016/j.ejso.2020.02.019. Epub 2020 Feb 20. Eur J Surg Oncol. 2020. PMID: 32147426 Review.
Adjuvant treatment of colorectal cancer (current expert opinion derived from the Third International Conference: Perspectives in Colorectal Cancer, Dublin, 2001).
Van Cutsem E, Dicato M, Wils J, Cunningham D, Diaz-Rubio E, Glimelius B, Haller D, Johnston P, Kerr D, Koehne CH, Labianca R, Minsky B, Nordlinger B, Roth A, Rougier P, Schmoll HJ. Van Cutsem E, et al. Among authors: koehne ch. Eur J Cancer. 2002 Jul;38(11):1429-36. doi: 10.1016/s0959-8049(02)00122-3. Eur J Cancer. 2002. PMID: 12110487
COX-2 inhibition and colorectal cancer.
Koehne CH, Dubois RN. Koehne CH, et al. Semin Oncol. 2004 Apr;31(2 Suppl 7):12-21. doi: 10.1053/j.seminoncol.2004.03.041. Semin Oncol. 2004. PMID: 15252926 Review.
Comparison of pegfilgrastim on day 2 vs. day 4 as primary prophylaxis of intense dose-dense chemotherapy in patients with node-positive primary breast cancer within the prospective, multi-center GAIN study: (GBG 33).
Loibl S, Mueller V, von Minckwitz G, Conrad B, Koehne CH, Kremers S, Forstbauer H, Linder M, Nekljudova V, Moebus V; GBG/AGO/NOGGO study groups. Loibl S, et al. Among authors: koehne ch. Support Care Cancer. 2011 Nov;19(11):1789-95. doi: 10.1007/s00520-010-1020-9. Epub 2010 Oct 16. Support Care Cancer. 2011. PMID: 20953803 Clinical Trial.
Efficacy of the irreversible ErbB family blocker afatinib in epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI)-pretreated non-small-cell lung cancer patients with brain metastases or leptomeningeal disease.
Hoffknecht P, Tufman A, Wehler T, Pelzer T, Wiewrodt R, Schütz M, Serke M, Stöhlmacher-Williams J, Märten A, Maria Huber R, Dickgreber NJ; Afatinib Compassionate Use Consortium (ACUC). Hoffknecht P, et al. J Thorac Oncol. 2015 Jan;10(1):156-63. doi: 10.1097/JTO.0000000000000380. J Thorac Oncol. 2015. PMID: 25247337 Free PMC article.
CXCR4 and hif-1α as prognostic molecular markers for stage 3 colon cancer patients: post hoc analysis of the randomized, multicenter phase 3 PETACC-2 trial dataset.
Maderer A, Fiteni F, Tanis E, Mauer M, Schmitt T, Aust DE, Lutz MP, Roelofson F, Gog C, Weinmann A, Koehne CH, Moehler M, Thomaidis T. Maderer A, et al. Among authors: koehne ch. Acta Oncol. 2021 Nov;60(11):1543-1547. doi: 10.1080/0284186X.2021.1959057. Epub 2021 Aug 6. Acta Oncol. 2021. PMID: 34355650 Clinical Trial. No abstract available.
20 results